Results: We found that adenosine agonist (NECA) inhibits the effects of adenosine diphosphate (ADP)-induced platelet aggregation in a dose dependent manner by elevating cAMP (n = 8). Additionally, A2a receptor antagonist, Sch 58261, was shown to block NECA inhibition of platelet aggregation ...